Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ANTX
#3989
AN2 Therapeutics, Inc. Common Stock
3.0
2
USD
+1.34%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+1.34%
Aylık Değişim
-37.34%
6 aylık değişim
+145.53%
Yıllık Değişim
+141.60%
Önceki Kapanış
2.9
8
Open
2.9
3
Bid
Ask
Low
2.8
7
High
3.0
6
Hacim
226
Piyasalar
ABD Borsası
Sağlık Hizmetleri
ANTX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
19.4 M
29.77 M
30.1 M
35.94 M
—
Valuation ratios
Enterprise value
161.37 M
575.89 M
20.19 M
21.03 M
69.63 M
Price to earnings ratio
-3.48
-7.25
-0.8
-0.98
-3.87
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
-4.46
-8.8
-0.84
-1.15
-4.29
Price to book ratio
1.56
3.76
0.5
0.65
1
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.4
-0.47
-0.56
-0.57
-0.5
Return on equity %
-0.43
-0.52
-0.63
-0.66
-0.56
Return on invested capital %
-2 741.62
-1 426.87
-1 148.94
-2 473.61
—
Gross margin %
—
—
—
—
—
Operating margin %
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
13.72
7.87
10.07
6.87
40.36
Inventory turnover
—
—
—
—
—
Asset turnover
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
-2.18
-2.26
-1.65
-0.99
-0.99
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
6.47
4.55
2.8
1.92
8.28
Net current asset value per share
6.43
4.68
2.89
1.98
8.65
Tangible book value per share
6.22
5.28
2.74
1.76
8.47
Working capital per share
5.96
4.09
2.6
1.7
7.75
Book value per share
6.22
5.28
2.74
1.76
8.47
Haberler
AN2 Therapeutics, Jefferies ile 80 milyon dolarlık anlaşma imzaladı
AN2 Therapeutics akciğer enfeksiyonu ilacı için faz 2 denemesini başlattı
AN2 Therapeutics Stock Cools Off After 90% Rally - AN2 Therapeutics (NASDAQ:ANTX)
AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action? - AN2 Therapeutics (NASDAQ:ANTX)
AN2 Therapeutics özel satışta 40 milyon dolar topladı
AN2 Therapeutics raises $40M in private placement
AN2 Therapeutics PV/n için epetraborole Faz 2 denemesi planlıyor
AN2 Therapeutics plans phase 2 trial of epetraborole in PV
AN2 Therapeutics, Sarah Williams’ı baş muhasebe yetkilisi olarak atadı
AN2 Therapeutics appoints Sarah Williams as principal accounting officer
FDA clears IND for epetraborole trial in mycobacterium abscessus
AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?